4.7 Article

Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Heterodimerization within the TREK channel subfamily produces a diverse family of highly regulated potassium channels

Joshua Levitz et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Multidisciplinary Sciences

Mixing and matching TREK/TRAAK subunits generate heterodimeric K2P channels with unique properties

Sandy Blin et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Review Psychiatry

The primacy of mania: A reconsideration of mood disorders

Athanasios Koukopoulos et al.

EUROPEAN PSYCHIATRY (2009)

Article Biochemistry & Molecular Biology

Antipsychotics inhibit TREK but not TRAAK channels

Susanne Thummler et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Psychiatry

Animal models of mood disorders: recent developments

John F. Cryan et al.

CURRENT OPINION IN PSYCHIATRY (2007)

Article Cell Biology

Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor

Dawon Kang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)

Article Neurosciences

Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype

Catherine Heurteaux et al.

NATURE NEUROSCIENCE (2006)

Article Neurosciences

Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK

D Kang et al.

JOURNAL OF PHYSIOLOGY-LONDON (2005)

Article Pharmacology & Pharmacy

Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine

LE Kennard et al.

BRITISH JOURNAL OF PHARMACOLOGY (2005)

Review Pharmacology & Pharmacy

Physiology and pharmacology of two-pore domain potassium channels

D Kim

CURRENT PHARMACEUTICAL DESIGN (2005)

Review Pharmacology & Pharmacy

Fatty acid-sensitive two-pore domain K+ channels

D Kim

TRENDS IN PHARMACOLOGICAL SCIENCES (2003)

Review Clinical Neurology

Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection

XH Li et al.

BIPOLAR DISORDERS (2002)

Article Pharmacology & Pharmacy

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

MA Frye et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)

Article Biochemistry & Molecular Biology

TREK-1 is a heat-activated background K+ channel

F Maingret et al.

EMBO JOURNAL (2000)